US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

42.47

+0.51461.23%

Post-market: 41.95-0.5146-1.21%16:10 EDT

Volume:168

Turnover:7K

Market Cap:31.85M

PE:- -

High:42.47

Open:41.95

Low:42.47

Close:41.95

52wk High:43.51

52wk Low:29.80

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.21

T/O Rate:0.02%

Dividend:0.14

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Is Krystal Biotech (KRYS) Overvalued On Its KB801 Patent Data Update?

Simply Wall St.

Krystal Biotech - Discontinues Clinical Study to Advance KB801 into Pivotal Trial; no Safety Concerns Observed - SEC Filing

THOMSON REUTERS

Krystal Biotech - no Further Subject-level Updates from Discontinued Study; Pivotal Trial Results Expected in Due Course - SEC Filing

THOMSON REUTERS

Krystal Biotech - Files Response with Uspto on KB801 Patent Application - SEC Filing

THOMSON REUTERS

Construction Firm Tutor Perini Jumps on S&P Smallcap Inclusion

Ligand Pharmaceuticals Inc : Citigroup Resumes Coverage with Buy Rating; Price Target $387

THOMSON REUTERS

Ligand resumed with a Buy at Citi

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Disposes of 5,000 Shares for $115,000

Tutor Perini Set to Join the S&P SmallCap 600 Index

MT Newswires Live

Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24

Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24

S&P Dow Jones Indices Says Krystal Biotech Inc. Will Replace Taylor Morrison Home Corp. in the S&P Midcap 400

THOMSON REUTERS

Ligand price target raised to $345 from $330 at Craig-Hallum

Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91

Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million

Natera Says Finalized Moldx Coverage Expands Prospera Surveillance Testing for Kidney, Heart, Lung Transplants

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Guardant Health is Maintained at Buy by Guggenheim

Ligand Pharmaceuticals Inc : Benchmark Raises Target Price to $335 from $275

THOMSON REUTERS

Guardant Health price target raised to $190 from $160 at Guggenheim

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/HELX/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":42.4684,"timestamp":1788379200000,"preClose":41.9538,"halted":0,"volume":168,"hourTrading":{"tag":"盘后","latestPrice":41.9538,"preClose":42.4684,"latestTime":"16:10 EDT","volume":7,"amount":297.2788,"timestamp":1788379804853,"change":-0.5146,"changeRate":-0.012117,"amplitude":0},"delay":0,"changeRate":0.012265873413135437,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Not Yet Opened","change":0.5146,"latestTime":"09-02 16:00:00 EDT","open":41.9538,"high":42.4684,"low":42.4684,"amount":7146,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":0,"adr":0,"exchange":"CBOE","adjPreClose":41.9538,"sharesOutstanding":650000,"nav":42.018,"aum":31513603.15,"dividendRate":0.003346,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.9538,"preClose":42.4684,"latestTime":"16:10 EDT","volume":7,"amount":297.2788,"timestamp":1788379804853,"change":-0.5146,"changeRate":-0.012117,"amplitude":0},"volumeRatio":0.205731,"impliedVol":0.0655,"impliedVolPercentile":0.0717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.205731,"shares":750000,"dividePrice":0.1421,"high":42.4684,"amplitude":0,"preClose":41.9538,"low":42.4684,"week52Low":29.8,"pbRate":"--","week52High":43.5089,"institutionHeld":0,"latestPrice":42.4684,"eps":0,"divideRate":0.003346,"volume":168,"delay":0,"ttmEps":0,"open":41.9538,"prevYearClose":36.3062,"prevWeekClose":42.0768,"prevMonthClose":41.805,"prevQuarterClose":39.9651,"fiveDayClose":43.4241,"twentyDayClose":40.0248,"sixtyDayClose":35.7434},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653735352","title":"Is Krystal Biotech (KRYS) Overvalued On Its KB801 Patent Data Update?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653735352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653735352?lang=en_us&edition=fundamental","pubTime":"2026-07-22 11:30","pubTimestamp":1784691056,"startTime":"0","endTime":"0","summary":"Why KB801’s Patent Filing Matters For Krystal Biotech Stock\nKrystal Biotech (KRYS) recently filed a response with the U.S. Patent and Trademark Office for KB801, sharing previously undisclosed single patient data on corneal defect closure from a discontinued neurotrophic keratitis study.\nThe company stressed that this observation comes from one patient and is not a substitute for clinical trial results. However, the disclosure offers investors a clearer view of how KB801 is progressing toward...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/is-krystal-biotech-krys-overvalued-on-its-kb801-patent-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/is-krystal-biotech-krys-overvalued-on-its-kb801-patent-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","HELX","BK4581","DCF","KRYS","XBI","PSCH","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653857567","title":"Krystal Biotech - Discontinues Clinical Study to Advance KB801 into Pivotal Trial; no Safety Concerns Observed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653857567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653857567?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","KRYS","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653785755","title":"Krystal Biotech - no Further Subject-level Updates from Discontinued Study; Pivotal Trial Results Expected in Due Course - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653785755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653785755?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRYS","PSCH","HELX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653734785","title":"Krystal Biotech - Files Response with Uspto on KB801 Patent Application - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653734785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653734785?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","PSCH","BK4139","KRYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653158270","title":"Construction Firm Tutor Perini Jumps on S&P Smallcap Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2653158270","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653158270?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:57","pubTimestamp":1784638676,"startTime":"0","endTime":"0","summary":"BUZZ-Construction firm Tutor Perini jumps on S&P SmallCap inclusion** Infrastructure contractor Tutor Perini'sTPC.Nshares up 6.7% before the bell on Tues at $85.93 as co poised to join S&P SmallCap 600 index.SPCY** TPC to replace Krystal BiotechKRYS.Oin SPCY effective Fri, Jul 24, S&P Dow Jones Indices said late Mon** KRYS migrating to S&P MidCap 400 index.IDXto replace homebuilder Taylor MorrisonTMHC.N, which is beingacquiredby Berkshire HathawayBRKa.N** Shares of KRYS up 0.2% at $340.06 before the bell** Stephens analyst Melissa Roberts said in a note she expects passive funds will need to buy 6 mln TPC shares, which implies about 11 days of buying demand** Sylmar, California-based TPC has ~52.6 mln shares outstanding for $4.2 bln market cap** At Mon close, TPC stock up 20% YTD** All 5 brokerages covering the stock are bullish and their median PT is $118, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL6N43N0NS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","PSCH","TMHC","HELX","TPC","LU2065171311.SGD","LU2065171402.SGD","KRYS","BK4088","LU2065169927.USD","BK4139","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653275043","title":"Ligand Pharmaceuticals Inc : Citigroup Resumes Coverage with Buy Rating; Price Target $387","url":"https://stock-news.laohu8.com/highlight/detail?id=2653275043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653275043?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:12","pubTimestamp":1784628768,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0566484027.USD","LGND","BK4007","IE0009354923.USD","HELX","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927662","title":"Ligand resumed with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927662?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:10","pubTimestamp":1784628616,"startTime":"0","endTime":"0","summary":"Citi resumed coverage of Ligand (LGND) with a Buy rating and $387 price target following the close of the Xoma acquisition. The firm views the deal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ligand-resumed-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ligand-resumed-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","HELX","IE0009354923.USD","LU1559883803.SGD","BK4139","LGND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653241139","title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Disposes of 5,000 Shares for $115,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2653241139","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653241139?lang=en_us&edition=fundamental","pubTime":"2026-07-21 07:20","pubTimestamp":1784589629,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 5,000 common shares on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL41gDrl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Disposes of 5,000 Shares for $115,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249554","title":"Tutor Perini Set to Join the S&P SmallCap 600 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249554","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249554?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:44","pubTimestamp":1784583863,"startTime":"0","endTime":"0","summary":"Tutor Perini (TPC) will join the S&P SmallCap 600 index before market opens on July 24, the S&P Dow Jones Indices said in a late Monday statement.The company will replace Krystal Biotech (KRYS), which will join the S&P MidCap 400 index","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SAA","HELX","XSHQ","TPC","XSMO","LU2065169927.USD","SDD","RZV","QVMS","BK7136","XJR","KRYS","LU2065170008.USD","BK4129","TPC.AU","LU2065171402.SGD","LU2065171311.SGD","SIXS","SBB","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249586","title":"Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249586","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249586?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:20","pubTimestamp":1784582423,"startTime":"0","endTime":"0","summary":"Berkshire Hathaway (BRK.B) (BRK.A) (BRK.A/BRK.B) is acquiring Taylor Morrison Home (TMHC) in a deal expected to close on or about that date, pendin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/krystal-biotech-to-replace-taylor-morrison-in-sp-400-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/krystal-biotech-to-replace-taylor-morrison-in-sp-400-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","TMHC","BK4139","HELX","BK4088","KRYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249321","title":"Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249321","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249321?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:20","pubTimestamp":1784582414,"startTime":"0","endTime":"0","summary":"17:18 EDT Tutor Perini (TPC) to replace Krystal Biotech (KRYS) in S&P 600 at open on 7/24 Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tutor-perini-to-replace-krystal-biotech-in-sp-600-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tutor-perini-to-replace-krystal-biotech-in-sp-600-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","BK4585","LU2065170008.USD","LU2065171311.SGD","BK4588","TPC","BK4581","LU2065169927.USD","PSCH","XBI","BK4129","BK4139","KRYS","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653467762","title":"S&P Dow Jones Indices Says Krystal Biotech Inc. Will Replace Taylor Morrison Home Corp. in the S&P Midcap 400","url":"https://stock-news.laohu8.com/highlight/detail?id=2653467762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653467762?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:17","pubTimestamp":1784582265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M11M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRYS","TMHC","BK4088","HELX","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652099215","title":"Ligand price target raised to $345 from $330 at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2652099215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652099215?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:46","pubTimestamp":1784551576,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Matt Hewitt raised the firm’s price target on Ligand (LGND) to $345 from $330 and keeps a Buy rating on the shares. Following ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ligand-price-target-raised-to-345-from-330-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ligand-price-target-raised-to-345-from-330-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LGND","IE0009354923.USD","HELX","LU0566484027.USD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652236851","title":"Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2652236851","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652236851?lang=en_us&edition=fundamental","pubTime":"2026-07-18 09:05","pubTimestamp":1784336751,"startTime":"0","endTime":"0","summary":"Natera co-founder, Director Sheena Jonathan disposes of 1,500 common shares worth $410,322.91Natera director and co-founder Sheena Jonathan sold 1,500 common shares on July 15, 2026 at about $273 to $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260718:nNDL9nvf8P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0963586101.USD","HELX","LU2065170008.USD","LU0345770993.USD","LU1064131342.USD","LU2264538146.SGD","LU1988902786.USD","LU2065731478.USD","GNOM","LU2324357040.USD","LU0053671581.USD","LU2065171311.SGD","LU0012050646.USD","LU2065171402.SGD","LU2065169927.USD","LU0106261612.USD","LU0345770308.USD","NTRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652330702","title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2652330702","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652330702?lang=en_us&edition=fundamental","pubTime":"2026-07-18 07:24","pubTimestamp":1784330673,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief People Officer Francis Lo disposes of 105,762 common shares worth $2.39 millionAdaptive Biotechnologies Chief People Officer Francis Lo sold 105,762 shares on July 15 at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL2NV8mT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT","BK4121","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652420159","title":"Natera Says Finalized Moldx Coverage Expands Prospera Surveillance Testing for Kidney, Heart, Lung Transplants","url":"https://stock-news.laohu8.com/highlight/detail?id=2652420159","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652420159?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:37","pubTimestamp":1784241425,"startTime":"0","endTime":"0","summary":"Natera says finalized MolDx coverage expands Prospera surveillance testing for kidney, heart, lung transplantsNatera flagged a final MolDx local coverage determination (L40060) expanding Medicare cove","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL6Wxmx2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU0963586101.USD","LU2065171311.SGD","LU1064131342.USD","LU2065169927.USD","LU0345770308.USD","BK4139","LU0012050646.USD","LU2324357040.USD","LU0106261612.USD","HELX","LU1988902786.USD","NTRA","LU2264538146.SGD","LU2065171402.SGD","LU2065731478.USD","LU0053671581.USD","LU2065170008.USD","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652278224","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2652278224","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652278224?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:57","pubTimestamp":1784235433,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,941.64Guardant Health director Tariq Musa cut his stake to 11,182 shares following a sale disclosed in a Form 4.Musa sold 11","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDLc18J55:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GDOC","BK4551","LU0109394709.USD","LU0889565916.HKD","PTH","EKG","BK4196","BK4588","GNOM","HELX","LU0320765992.SGD","BK4585","GH","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651290441","title":"Guardant Health is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651290441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651290441?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:10","pubTimestamp":1784203800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 16, 2026 08:10 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","GDOC","GH","EKG","BK4588","HELX","PTH","LFSC","BK4196","LU0109394709.USD","BK4551","LU0320765992.SGD","LU0889565916.HKD","BK4585","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651446790","title":"Ligand Pharmaceuticals Inc : Benchmark Raises Target Price to $335 from $275","url":"https://stock-news.laohu8.com/highlight/detail?id=2651446790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651446790?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:20","pubTimestamp":1784200830,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I17S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGND","IE0009354923.USD","LU0566484027.USD","HELX","LU1559883803.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651344620","title":"Guardant Health price target raised to $190 from $160 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344620?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199651,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Guardant Health (GH) to $190 from $160 and keeps a Buy rating on the shares. The firm says its Q2 web ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4585","BK4196","GDOC","LU0320765992.SGD","BK4588","LU0889565916.HKD","GH","GNOM","HELX","BK4551","BK4535","LFSC","PTH","EKG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}